212 related articles for article (PubMed ID: 33532324)
1. Population-based outcome of muscle-invasive bladder cancer following radical cystectomy: who can benefit from adjuvant chemotherapy?
Tian J; Sun J; Fu G; Xu Z; Chen X; Shi Y; Jin B
Transl Androl Urol; 2021 Jan; 10(1):356-373. PubMed ID: 33532324
[TBL] [Abstract][Full Text] [Related]
2. A novel nomogram based on body composition and nutritional indicators to predict the prognosis of patients with muscle-invasive bladder cancer undergoing radical cystectomy.
Zhong X; Pan Y; Wu K; Wang L; Dou P; Tan P; Zhang P; Li X
Cancer Med; 2023 Dec; 12(24):21627-21638. PubMed ID: 37975152
[TBL] [Abstract][Full Text] [Related]
3. Development and validation of a prognostic nomogram for predicting cancer-specific survival after radical cystectomy in patients with bladder cancer:A population-based study.
Yang Z; Bai Y; Liu M; Hu X; Han P
Cancer Med; 2020 Dec; 9(24):9303-9314. PubMed ID: 33063464
[TBL] [Abstract][Full Text] [Related]
4. The clinical characteristics, novel predictive tool, and risk classification system for primary Ewing sarcoma patients that underwent chemotherapy: A large population-based retrospective cohort study.
Huang C; Yu QP; Ding Z; Zhou Z; Shi X
Cancer Med; 2023 Mar; 12(5):6244-6259. PubMed ID: 36271609
[TBL] [Abstract][Full Text] [Related]
5. Prediction of cancer-specific survival after radical cystectomy in pT4a urothelial carcinoma of the bladder: development of a tool for clinical decision-making.
Aziz A; Shariat SF; Roghmann F; Brookman-May S; Stief CG; Rink M; Chun FK; Fisch M; Novotny V; Froehner M; Wirth MP; Schnabel MJ; Fritsche HM; Burger M; Pycha A; Brisuda A; Babjuk M; Vallo S; Haferkamp A; Roigas J; Noldus J; Stredele R; Volkmer B; Bastian PJ; Xylinas E; May M
BJU Int; 2016 Feb; 117(2):272-9. PubMed ID: 25381844
[TBL] [Abstract][Full Text] [Related]
6. Predictive Value of the Log Odds of Negative Lymph Nodes/T Stage as a Novel Prognostic Factor in Bladder Cancer Patients After Radical Cystectomy.
Chen T; Zhan X; Chen X; Jiang M; Wan H; Fu B; Chen L
Front Oncol; 2022; 12():895413. PubMed ID: 35928878
[TBL] [Abstract][Full Text] [Related]
7. Prognostic nomogram for estimating survival in patients with resected muscle-invasive bladder cancer receiving chemotherapy.
Hu B; Chen R; Chen G; Zheng P; Fu B
Front Surg; 2023; 10():1121184. PubMed ID: 36911611
[TBL] [Abstract][Full Text] [Related]
8. A panel of systemic inflammatory response biomarkers for outcome prediction in patients treated with radical cystectomy for urothelial carcinoma.
Schuettfort VM; D'Andrea D; Quhal F; Mostafaei H; Laukhtina E; Mori K; König F; Rink M; Abufaraj M; Karakiewicz PI; Luzzago S; Rouprêt M; Enikeev D; Zimmermann K; Deuker M; Moschini M; Sari Motlagh R; Grossmann NC; Katayama S; Pradere B; Shariat SF
BJU Int; 2022 Feb; 129(2):182-193. PubMed ID: 33650265
[TBL] [Abstract][Full Text] [Related]
9. Metastasis Pattern and Survival Analysis in Primary Small Bowel Adenocarcinoma: A SEER-Based Study.
Gu Y; Deng H; Wang D; Li Y
Front Surg; 2021; 8():759162. PubMed ID: 34950695
[No Abstract] [Full Text] [Related]
10. Karnofsky performance status predicts overall survival, cancer-specific survival, and progression-free survival following radical cystectomy for urothelial carcinoma.
Evers PD; Logan JE; Sills V; Chin AI
World J Urol; 2014 Apr; 32(2):385-91. PubMed ID: 23756991
[TBL] [Abstract][Full Text] [Related]
11. Prognostic nutritional index combined with NLR to construct a survival prediction model and decision analysis of patients with muscle-invasive bladder cancer after surgery.
Wang J; Shi H; Fan Z; Yang J; Zheng Y; Zeng D; Zhang J; Hai B
Cancer Med; 2023 Jul; 12(13):14207-14224. PubMed ID: 37199384
[TBL] [Abstract][Full Text] [Related]
12. Prognosis prediction model for a special entity of gastric cancer, linitis plastica.
Chen X; Zhi Y; Lin Z; Ma J; Mou W; Yu J
J Gastrointest Oncol; 2021 Apr; 12(2):307-327. PubMed ID: 34012628
[TBL] [Abstract][Full Text] [Related]
13. Prognostic nomograms for predicting cause-specific survival and overall survival of stage I-III colon cancer patients: a large population-based study.
Zhou Z; Mo S; Dai W; Xiang W; Han L; Li Q; Wang R; Liu L; Zhang L; Cai S; Cai G
Cancer Cell Int; 2019; 19():355. PubMed ID: 31889907
[TBL] [Abstract][Full Text] [Related]
14. Development and validation of a nomogram to predict the prognosis of patients with gastric cardia cancer.
Shi X; Xu L; Ma B; Wang S
Sci Rep; 2020 Aug; 10(1):14143. PubMed ID: 32839498
[TBL] [Abstract][Full Text] [Related]
15. Predictive value of preoperative lymphocyte-to-monocyte ratio on survival outcomes in bladder cancer patients after radical cystectomy.
Bi H; Yan Y; Wang D; Qin Z; Wang G; Ma L; Huang Y; Lu J
J Cancer; 2021; 12(2):305-315. PubMed ID: 33391427
[No Abstract] [Full Text] [Related]
16. A nomogram for predicting overall survival in patients with low-grade endometrial stromal sarcoma: A population-based analysis.
Wu J; Zhang H; Li L; Hu M; Chen L; Xu B; Song Q
Cancer Commun (Lond); 2020 Jul; 40(7):301-312. PubMed ID: 32558385
[TBL] [Abstract][Full Text] [Related]
17. Development and Internal Validation of a Nomogram Predicting Overall Survival Based on Log ODDS of Positive Lymph-Nodes for Post Radical Cystectomy Patients in Muscle Invasive Carcinoma of Bladder.
Patel KN; Salunke A; Sharma M; Puj K; Rathod P; Warikoo V; Bakshi G; Pandya SJ
Clin Genitourin Cancer; 2023 Jun; 21(3):e153-e165. PubMed ID: 36549982
[TBL] [Abstract][Full Text] [Related]
18. Development and validation of nomograms for predicting survival of elderly patients with stage I small-cell lung cancer.
Yang Y; Sun S; Wang Y; Xiong F; Xiao Y; Huang J
Bosn J Basic Med Sci; 2021 Oct; 21(5):632-641. PubMed ID: 33577444
[TBL] [Abstract][Full Text] [Related]
19. The Cancer of the Bladder Risk Assessment (COBRA) score for estimating cancer-specific survival after radical cystectomy: external validation in a large bi-institutional cohort.
Muilwijk T; Akand M; Soria F; Giordano A; Milenkovic U; Moris L; Gevaert T; Van Poppel H; Albersen M; Gontero P; Joniau S
BJU Int; 2020 Dec; 126(6):704-714. PubMed ID: 32640103
[TBL] [Abstract][Full Text] [Related]
20. Modeling 1-year Relapse-free Survival After Neoadjuvant Chemotherapy and Radical Cystectomy in Patients with Clinical T2-4N0M0 Urothelial Bladder Carcinoma: Endpoints for Phase 2 Trials.
Bandini M; Briganti A; Plimack ER; Niegisch G; Yu EY; Bamias A; Agarwal N; Sridhar SS; Sternberg CN; Vaishampayan U; Théodore C; Rosenberg JE; Bellmunt J; Galsky MD; Montorsi F; Necchi A
Eur Urol Oncol; 2019 May; 2(3):248-256. PubMed ID: 31200838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
